Results 131 to 140 of about 202,574 (385)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To determine the concentration of glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and plasma in Alexander disease (AxD) and whether GFAP levels are predictive of disease phenotypes. Methods CSF and plasma were collected (longitudinally when available) from AxD participants and non‐AxD controls.
Amy T. Waldman +9 more
wiley +1 more source
ÉTUDE COÛT-EFFICACITÉ DE LA FILIÈRE STEMI DU CHUV À COURT TERME [PDF]
, 2014 Introduction : Les maladies cardiovasculaires sont la première cause de mortalité dans le monde selon l'organisation mondiale de la santé. La prise en charge optimale d'un infarctus du myocarde avec sus décalage du segment ST nécessite une reperfusion de
GROS, L.
core
Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan +3 more
wiley +1 more source
Région des Laurentides : Les agressions dans les urgences générales et psychiatriques [PDF]
, 1997 Larose, Diane
core +1 more source
Epidemiology and characteristics of febrile seizures in children [PDF]
, 2013 peer reviewedRésumé : Les convulsions fébriles (CF), malgré leur bénignité, font toujours l’objet de discussions concernant les investigations à entreprendre et l’attitude thérapeutique à adopter.
DUBRU, Jean-Marie +5 more
core
Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler +20 more
wiley +1 more source
Hospitalisations pour effet indésirable médicamenteux: recensement prospectif dans un Service d'urgences médicales. [PDF]
, 1998 [Table des matières] I. Mise en perspective et méthodologie. II. Données démographiques : intoxications volontaires: descriptif succinct. III. Effets indésirables, descriptifs. 1. Médicaments. 2. Effets indésirables. 3. Imputabilité. 4. Gravité.
Biollaz, Jérôme +5 more
core
Arthritis Care &Research, EarlyView.Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen +14 more
wiley +1 more source
Urge 1 Study – A randomized cross-over clinical trial to compare medical treatment of urgency urinary incontinence with surgical treatment [PDF]
, 2017 Wolfram Jäger +3 more
openalex +1 more source